BridgeMD
New treatment option for Chronic Kidney Disease(CKD)
Official title An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
ClinicalTrials.gov ID: NCT06754280
What this study is testing
- What it's testing
- RESET-CKD is evaluating an intervention to support Black adults with chronic kidney disease (CKD) to reduce their sedentary (e.g., sitting) time. Half of the participants will be randomized to the intervention, where the goal is to support individuals to reduce their sitting time, and the other half will be randomized to an attention control condition that provides CKD-related education not related to sedentary behavior.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 80
You may be able to join if
- Self-identifies as Black or African American
- Age ≥35 to ≤80 years old
- CKD Stage 1-4
- Self-reported 6 or more hours/day of sedentary time
- Ability to speak/read/understand English
You likely can't join if
- Being unable to walk 1 block
- Being unable to stand from a seated position without assistance
- Using a wheelchair, walker, or cane for all of their ambulation
- Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA...
- Kidney transplant
- Any other condition that the investigator considers precludes participation in the trial
See the full eligibility criteria
- Self-identifies as Black or African American
- Age ≥35 to ≤80 years old
- CKD Stage 1-4
- Self-reported 6 or more hours/day of sedentary time
- Ability to speak/read/understand English
- Has access to a telephone
- Being unable to walk 1 block
- Being unable to stand from a seated position without assistance
- Using a wheelchair, walker, or cane for all of their ambulation
- Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude...
- Kidney transplant
- Any other condition that the investigator considers precludes participation in the trial
- Participated in the Patient Advisory Board
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.